Role of Marichadi gutika and sitopaladi vati in management of Shwasa with special reference to Chronic obstructive pulmonary disease (COPD)

An Open Labelled Active Controlled Randomized Clinical Study to Evaluate the efficacy of Marichadi Gutika in Shwasa with special reference to Chronic Obstructive Pulmonary Disease (COPD) - NIL

Status

Active, not recruiting

Phases

Phase 3

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2024/04/066421

Enrollment

Registered

2024-04-29

Start date

Unknown

Completion date

Unknown

Last updated

2024-05-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: J449- Chronic obstructive pulmonary disease, unspecified

Interventions

None listed

Eligibility

Inclusion criteria

Inclusion criteria: 1.Age: From 30-year age to 70 years age (inclusive of either age) 2.Gender: Both. 3.Patients diagnosed with Mild to Moderate COPD as per GOLD Guidelines 2023 of Spirometry. 4.Patients willing and able to give written informed consent.

Exclusion criteria

Exclusion criteria: 1.Pregnant or lactating women. 2.Known case of Diabetes, uncontrolled hypertension, heart disease, secondary severe infections, Pleural effusion, pneumonia and pneumothorax, etc. 3.Severe and very severe cases of copd as per gold guidelines 2023. 4.History of upper or lower respiratory tract infection, within the previous 30 days. 5.History of lung resection of more than one full lobe. 6.Have a known sensitivity to formoterol, ipratropium, and salbutamol etc medicine. 7.Immunocompromised status such as HIV, tuberculosis, cancer, etc.

Design outcomes

Primary

Measure	Time frame
To Evaluate the Effect of Marichadi gutika in Shwasa with special reference to COPD on basis of Spirometry of GOLD guidelines 2023 of COPD.Timepoint: Baseline,Day 15,Day 30	—

Secondary

Measure	Time frame
Compare the efficacy of Marichadi gutika with Sitopaladi vati based on PEFR (through Peak flow meter), GOLD Guidelines 2023 of Spirometry for COPD. Compare the efficacy of Marichadi gutika with Sitopaladi vati on Based on CAT SCORE and Modified MRC dyspnea scale. Compare the efficacy of Marichadi gutika with Sitopaladi vati Based on Gradation/scoring of the signs and symptoms pattern for Shwasa. Compare the efficacy of Marichadi gutika with Sitopaladi vati Based on biochemical parameters-AEC and CBC.Timepoint: Baseline,Day 15,Day 30	—

Measure

Time frame

Compare the efficacy of Marichadi gutika with Sitopaladi vati based on PEFR (through Peak flow meter), GOLD Guidelines 2023 of Spirometry for COPD. Compare the efficacy of Marichadi gutika with Sitopaladi vati on Based on CAT SCORE and Modified MRC dyspnea scale. Compare the efficacy of Marichadi gutika with Sitopaladi vati Based on Gradation/scoring of the signs and symptoms pattern for Shwasa. Compare the efficacy of Marichadi gutika with Sitopaladi vati Based on biochemical parameters-AEC and CBC.Timepoint: Baseline,Day 15,Day 30

—

Countries

India

Contacts

Public ContactDr Manu R

Parul Institute of Ayurveda

manu.r260022@paruluniversity.ac.in8160858967

Outcome results